Clostridium difficile colitis: Factors influencing treatment failure and relapse a prospective evaluation

Satheesh Nair, Dhiraj Yadav, Marilou Corpuz, C. S. Pitchumoni

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

Objective: The aim of this study was to identify patient related factors that may influence the treatment response and relapse following Clostridium difficile (C. difficile) colitis. Methods: A total of 36 patients with C. difficile colitis were followed for 3 months. Age, sex, place of residence, severity of infection, treatment, underlying medical condition, and treatment were compared in patients who failed to respond to treatment in 14 days and in patients who relapsed after a successful treatment. Student's t test and Fisher's exact test were used to compare the groups. A p value of <0.05 was considered significant. Results: A low serum albumin (p = 0.016) and continuation of systemic antibiotic treatment were found to be associated with refractoriness to treatment. Continuation or restarting of antibiotics after successful treatment increases the risk of relapse (p = 0.003). The age, sex place of residence, underlying medical condition, and type of precipitating antibiotics had no effect on the treatment response and relapse. The severity of colitis and the type of therapy (metronidazole vs vancomycin) did not influence the treatment response or relapse. Conclusion: Low serum albumin serves as a useful marker for patients who require prolonged treatment for C. difficile colitis. It is prudent to review the need for the continuation of systemic antibiotic treatment, as it adversely affects the treatment response and increases the risk of relapse.

Original languageEnglish (US)
Pages (from-to)1873-1876
Number of pages4
JournalAmerican Journal of Gastroenterology
Volume93
Issue number10
DOIs
StatePublished - Oct 1998
Externally publishedYes

Fingerprint

Clostridium difficile
Colitis
Treatment Failure
Recurrence
Therapeutics
Anti-Bacterial Agents
Serum Albumin
Metronidazole
Vancomycin

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Clostridium difficile colitis : Factors influencing treatment failure and relapse a prospective evaluation. / Nair, Satheesh; Yadav, Dhiraj; Corpuz, Marilou; Pitchumoni, C. S.

In: American Journal of Gastroenterology, Vol. 93, No. 10, 10.1998, p. 1873-1876.

Research output: Contribution to journalArticle

@article{5ebcede20ba34b6c9cff0a4c4d2e7e1d,
title = "Clostridium difficile colitis: Factors influencing treatment failure and relapse a prospective evaluation",
abstract = "Objective: The aim of this study was to identify patient related factors that may influence the treatment response and relapse following Clostridium difficile (C. difficile) colitis. Methods: A total of 36 patients with C. difficile colitis were followed for 3 months. Age, sex, place of residence, severity of infection, treatment, underlying medical condition, and treatment were compared in patients who failed to respond to treatment in 14 days and in patients who relapsed after a successful treatment. Student's t test and Fisher's exact test were used to compare the groups. A p value of <0.05 was considered significant. Results: A low serum albumin (p = 0.016) and continuation of systemic antibiotic treatment were found to be associated with refractoriness to treatment. Continuation or restarting of antibiotics after successful treatment increases the risk of relapse (p = 0.003). The age, sex place of residence, underlying medical condition, and type of precipitating antibiotics had no effect on the treatment response and relapse. The severity of colitis and the type of therapy (metronidazole vs vancomycin) did not influence the treatment response or relapse. Conclusion: Low serum albumin serves as a useful marker for patients who require prolonged treatment for C. difficile colitis. It is prudent to review the need for the continuation of systemic antibiotic treatment, as it adversely affects the treatment response and increases the risk of relapse.",
author = "Satheesh Nair and Dhiraj Yadav and Marilou Corpuz and Pitchumoni, {C. S.}",
year = "1998",
month = "10",
doi = "10.1016/S0002-9270(98)00422-5",
language = "English (US)",
volume = "93",
pages = "1873--1876",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Clostridium difficile colitis

T2 - Factors influencing treatment failure and relapse a prospective evaluation

AU - Nair, Satheesh

AU - Yadav, Dhiraj

AU - Corpuz, Marilou

AU - Pitchumoni, C. S.

PY - 1998/10

Y1 - 1998/10

N2 - Objective: The aim of this study was to identify patient related factors that may influence the treatment response and relapse following Clostridium difficile (C. difficile) colitis. Methods: A total of 36 patients with C. difficile colitis were followed for 3 months. Age, sex, place of residence, severity of infection, treatment, underlying medical condition, and treatment were compared in patients who failed to respond to treatment in 14 days and in patients who relapsed after a successful treatment. Student's t test and Fisher's exact test were used to compare the groups. A p value of <0.05 was considered significant. Results: A low serum albumin (p = 0.016) and continuation of systemic antibiotic treatment were found to be associated with refractoriness to treatment. Continuation or restarting of antibiotics after successful treatment increases the risk of relapse (p = 0.003). The age, sex place of residence, underlying medical condition, and type of precipitating antibiotics had no effect on the treatment response and relapse. The severity of colitis and the type of therapy (metronidazole vs vancomycin) did not influence the treatment response or relapse. Conclusion: Low serum albumin serves as a useful marker for patients who require prolonged treatment for C. difficile colitis. It is prudent to review the need for the continuation of systemic antibiotic treatment, as it adversely affects the treatment response and increases the risk of relapse.

AB - Objective: The aim of this study was to identify patient related factors that may influence the treatment response and relapse following Clostridium difficile (C. difficile) colitis. Methods: A total of 36 patients with C. difficile colitis were followed for 3 months. Age, sex, place of residence, severity of infection, treatment, underlying medical condition, and treatment were compared in patients who failed to respond to treatment in 14 days and in patients who relapsed after a successful treatment. Student's t test and Fisher's exact test were used to compare the groups. A p value of <0.05 was considered significant. Results: A low serum albumin (p = 0.016) and continuation of systemic antibiotic treatment were found to be associated with refractoriness to treatment. Continuation or restarting of antibiotics after successful treatment increases the risk of relapse (p = 0.003). The age, sex place of residence, underlying medical condition, and type of precipitating antibiotics had no effect on the treatment response and relapse. The severity of colitis and the type of therapy (metronidazole vs vancomycin) did not influence the treatment response or relapse. Conclusion: Low serum albumin serves as a useful marker for patients who require prolonged treatment for C. difficile colitis. It is prudent to review the need for the continuation of systemic antibiotic treatment, as it adversely affects the treatment response and increases the risk of relapse.

UR - http://www.scopus.com/inward/record.url?scp=0032435128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032435128&partnerID=8YFLogxK

U2 - 10.1016/S0002-9270(98)00422-5

DO - 10.1016/S0002-9270(98)00422-5

M3 - Article

C2 - 9772047

AN - SCOPUS:0032435128

VL - 93

SP - 1873

EP - 1876

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 10

ER -